<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="149651">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01879488</url>
  </required_header>
  <id_info>
    <org_study_id>AeroVent-01</org_study_id>
    <nct_id>NCT01879488</nct_id>
  </id_info>
  <brief_title>Effect of Ventilation Mode on Lung Deposition of a Radiolabeled Aerosol During Mechanical Ventilation: Barometric Versus Volumetric</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</source>
  <oversight_info>
    <authority>Belgium: Institutional Review Board</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      Controlling the respiratory pattern of mechanically ventilated patients in volume control
      mode is recommended during nebulization.  No studies looked into conditions of nebulization
      during assisted mechanical ventilation to define the optimal nebulization technique and its
      effect on pulmonary deposition.

      The aim of this study is to analyse the effect of ventilation mode (barometric versus
      volumetric) on deposition by planar scintigraphy during mechanical ventilation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Pulmonary deposition</measure>
    <time_frame>Immediately after nebulization by imaging assessment, an expected average of 30 minutes</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Penetration index</measure>
    <time_frame>Immediately after nebulization by imaging assessment, an expected average of 30 minutes</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mechanical ventilation settings</measure>
    <time_frame>During nebulisation time, an expected average of 15 minutes</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lung function</measure>
    <time_frame>Preoperative assessment, the day before inclusion</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Post-operative Neurosurgery</condition>
  <arm_group>
    <arm_group_label>Nebulization during pressure support ventilation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients ventilated in pressure support mode during nebulization</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nebulization during volume assist control mode</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients ventilated in volume assist control mode during nebulization</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>technetium-99m - Diethylenetriaminepentaacetic acid</intervention_name>
    <arm_group_label>Nebulization during pressure support ventilation</arm_group_label>
    <arm_group_label>Nebulization during volume assist control mode</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Vibrating-mesh nebulizer</intervention_name>
    <arm_group_label>Nebulization during pressure support ventilation</arm_group_label>
    <arm_group_label>Nebulization during volume assist control mode</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Gamma scintigraphy</intervention_name>
    <arm_group_label>Nebulization during pressure support ventilation</arm_group_label>
    <arm_group_label>Nebulization during volume assist control mode</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Preoperative spirometry</intervention_name>
    <arm_group_label>Nebulization during pressure support ventilation</arm_group_label>
    <arm_group_label>Nebulization during volume assist control mode</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Invasive mechanical ventilation

          -  Healthy lungs

        Exclusion Criteria:

          -  Change of ventilation mode during nebulization
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierre-François Laterre</last_name>
    <role>Study Chair</role>
    <affiliation>Head of Intensive Care Unit, Cliniques Universitaires Saint-Luc</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pierre-François Laterre</last_name>
    <phone>0032 2/764 2735</phone>
    <email>pierre-francois.laterre@uclouvain.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cliniques Universitaires Saint-Luc</name>
      <address>
        <city>Brussels</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre-François Laterre, PhD</last_name>
      <email>pierre-francois.laterre@uclouvain.be</email>
    </contact>
    <investigator>
      <last_name>Jonathan Dugernier</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 9, 2014</lastchanged_date>
  <firstreceived_date>June 10, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Aerosol</keyword>
  <keyword>Lung deposition</keyword>
  <keyword>Mechanical ventilation</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pentetic Acid</mesh_term>
    <mesh_term>Edetic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
